Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative

Alexey A Rumyantsev¹, Alexandra S Tyulyandina¹, Alexey A Tryakin¹+2

• ¹Alexey A. Rumyantsev, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia; Alexandra S. Tyulyandina, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Sechenov First Moscow Medical University (Sechenov University), Moscow, Russia; Alexey A. Tryakin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Bashkir State Medical University, Ufa, Russia; Mikhail Y. Fedyanin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Moscow Medical City Hospital "Kommunarka," Moscow, Russia, N.I. Pirogov National Medical and Surgical Center, Moscow, Russia; and Sergey A. Tjulandin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.